Drugs that contain Insulin Aspart Recombinant

1. Novolog patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5618913 NOVO NORDISK INC Insulin analogues
Jun, 2014

(10 years ago)

US5618913

(Pediatric)

NOVO NORDISK INC Insulin analogues
Dec, 2014

(9 years ago)

US5866538 NOVO NORDISK INC Insulin preparations containing NaCl
Jun, 2017

(7 years ago)

US5866538

(Pediatric)

NOVO NORDISK INC Insulin preparations containing NaCl
Dec, 2017

(6 years ago)




Market Authorisation Date: 31 October, 2013

Treatment: NA

Dosage: INJECTABLE

More Information on Dosage

NOVOLOG family patents

Family Patents

2. Novolog Flexpen patent expiration

NOVOLOG FLEXPEN's oppositions filed in EPO
NOVOLOG FLEXPEN IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5618913 NOVO NORDISK INC Insulin analogues
Jun, 2014

(10 years ago)

US5618913

(Pediatric)

NOVO NORDISK INC Insulin analogues
Dec, 2014

(9 years ago)

US5866538 NOVO NORDISK INC Insulin preparations containing NaCl
Jun, 2017

(7 years ago)

US5866538

(Pediatric)

NOVO NORDISK INC Insulin preparations containing NaCl
Dec, 2017

(6 years ago)

USRE43834 NOVO NORDISK INC Injection syringe
Jan, 2019

(5 years ago)

US6004297 NOVO NORDISK INC Injection syringe
Jan, 2019

(5 years ago)

US6004297

(Pediatric)

NOVO NORDISK INC Injection syringe
Jul, 2019

(4 years ago)

USRE41956 NOVO NORDISK INC Dose setting limiter
Jan, 2021

(3 years ago)

USRE41956

(Pediatric)

NOVO NORDISK INC Dose setting limiter
Jul, 2021

(2 years ago)

US8579869 NOVO NORDISK INC Needle mounting system and a method for mounting a needle assembly
Jun, 2023

(11 months ago)

US7762994 NOVO NORDISK INC Needle mounting system and a method for mounting a needle assembly
May, 2024

(29 days ago)

US9265893 NOVO NORDISK INC Injection button
Sep, 2032

(8 years from now)




Market Authorisation Date: 31 October, 2013

Treatment: NA

Dosage: INJECTABLE

More Information on Dosage

NOVOLOG FLEXPEN family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Novolog Flextouch patent expiration

NOVOLOG FLEXTOUCH's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US5618913 NOVO NORDISK INC Insulin analogues
Jun, 2014

(10 years ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5618913

(Pediatric)

NOVO NORDISK INC Insulin analogues
Dec, 2014

(9 years ago)

US5866538 NOVO NORDISK INC Insulin preparations containing NaCl
Jun, 2017

(7 years ago)

US5866538

(Pediatric)

NOVO NORDISK INC Insulin preparations containing NaCl
Dec, 2017

(6 years ago)

US9486588 NOVO NORDISK INC Automatic injection device with reset feature
Jan, 2022

(2 years ago)

US6899699 NOVO NORDISK INC Automatic injection device with reset feature
Jan, 2022

(2 years ago)

US8672898 NOVO NORDISK INC Automatic injection device with reset feature
Jan, 2022

(2 years ago)

US8579869 NOVO NORDISK INC Needle mounting system and a method for mounting a needle assembly
Jun, 2023

(11 months ago)

US7762994 NOVO NORDISK INC Needle mounting system and a method for mounting a needle assembly
May, 2024

(29 days ago)

US8684969 NOVO NORDISK INC Injection device with torsion spring and rotatable display
Oct, 2025

(1 year, 3 months from now)

US9861757 NOVO NORDISK INC Injection device with an end of dose feedback mechanism
Jan, 2026

(1 year, 6 months from now)

US10357616 NOVO NORDISK INC Injection device with an end of dose feedback mechanism
Jan, 2026

(1 year, 6 months from now)

US9616180 NOVO NORDISK INC Automatic injection device with a top release mechanism
Jan, 2026

(1 year, 6 months from now)

US10376652 NOVO NORDISK INC Automatic injection device with a top release mechanism
Jan, 2026

(1 year, 6 months from now)

US9108002 NOVO NORDISK INC Automatic injection device with a top release mechanism
Jan, 2026

(1 year, 6 months from now)

US8920383 NOVO NORDISK INC Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left
Jul, 2026

(2 years from now)

US9775953 NOVO NORDISK INC Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left
Jul, 2026

(2 years from now)

US10220155 NOVO NORDISK INC Syringe device with a dose limiting mechanism and an additional safety mechanism
Jul, 2026

(2 years from now)

US7686786 NOVO NORDISK INC Dial-down mechanism for wind-up pen
Aug, 2026

(2 years from now)

USRE46363 NOVO NORDISK INC Dial-down mechanism for wind-up pen
Aug, 2026

(2 years from now)

US9687611 NOVO NORDISK INC Injection device with torsion spring and rotatable display
Feb, 2027

(2 years from now)

US9457154 NOVO NORDISK INC Injection device with an end of dose feedback mechanism
Sep, 2027

(3 years from now)

US9132239 NOVO NORDISK INC Dial-down mechanism for wind-up pen
Feb, 2032

(7 years from now)




Market Authorisation Date: 31 October, 2013

Treatment: NA

Dosage: INJECTABLE

More Information on Dosage

NOVOLOG FLEXTOUCH family patents

Family Patents

4. Novolog Innolet patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5618913 NOVO NORDISK INC Insulin analogues
Jun, 2014

(10 years ago)

US5618913

(Pediatric)

NOVO NORDISK INC Insulin analogues
Dec, 2014

(9 years ago)

US5866538 NOVO NORDISK INC Insulin preparations containing NaCl
Jun, 2017

(7 years ago)

US5866538

(Pediatric)

NOVO NORDISK INC Insulin preparations containing NaCl
Dec, 2017

(6 years ago)

USRE41956 NOVO NORDISK INC Dose setting limiter
Jan, 2021

(3 years ago)

USRE41956

(Pediatric)

NOVO NORDISK INC Dose setting limiter
Jul, 2021

(2 years ago)




Market Authorisation Date: 31 October, 2013

Treatment: NA

Dosage: INJECTABLE

More Information on Dosage

NOVOLOG INNOLET family patents

Family Patents

5. Novolog Penfill patent expiration

NOVOLOG PENFILL's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5626566 NOVO NORDISK INC Large dose pen
May, 2014

(10 years ago)

US5618913 NOVO NORDISK INC Insulin analogues
Jun, 2014

(10 years ago)

US5626566

(Pediatric)

NOVO NORDISK INC Large dose pen
Nov, 2014

(9 years ago)

US5693027 NOVO NORDISK INC Adaptor top
Dec, 2014

(9 years ago)

US5618913

(Pediatric)

NOVO NORDISK INC Insulin analogues
Dec, 2014

(9 years ago)

US5693027

(Pediatric)

NOVO NORDISK INC Adaptor top
Jun, 2015

(9 years ago)

US5866538 NOVO NORDISK INC Insulin preparations containing NaCl
Jun, 2017

(7 years ago)

US5866538

(Pediatric)

NOVO NORDISK INC Insulin preparations containing NaCl
Dec, 2017

(6 years ago)

US8579869 NOVO NORDISK INC Needle mounting system and a method for mounting a needle assembly
Jun, 2023

(11 months ago)

US7762994 NOVO NORDISK INC Needle mounting system and a method for mounting a needle assembly
May, 2024

(29 days ago)




Market Authorisation Date: 31 October, 2013

Treatment: NA

Dosage: INJECTABLE

More Information on Dosage

NOVOLOG PENFILL family patents

Family Patents